Special child winning fight vs leukemia still needs help | Inquirer News

Special child winning fight vs leukemia still needs help

Special child winning fight vs leukemia still needs help

Princess Angel Diaz

MANILA, Philippines — Aside from growing up with Down Syndrome, Princess Angel Diaz was diagnosed with acute lymphocytic leukemia in 2015 when she was just aged 7.

“She attends a Special Education (SPED) program where she is at Level 6. That’s how they are classified in school. They are not following regular grade levels,” said her 46-year-old mother, Jovelyn Diaz.

Article continues after this advertisement

The SPED school is in Antipolo City where Diaz, who is now aged 12, lives with her mother, father Jose, a construction worker, and two siblings.

FEATURED STORIES

After four years of chemotherapy at the Philippine Children’s Medical Center, Diaz will be watched by doctors for five years to make sure that she is truly cancer-free.

“I am asking for help from your readers because she undergoes a complete blood count test (P257) every month, a cytospin (P1,000) test every three months and a bone marrow test (P7,725) every six months. She also needs to take methotrexate (P2,466.75/monthly) and mercaptopurine (P1,418/monthly) every day for her complete healing,” Jovelyn said.

Article continues after this advertisement

Jovelyn Diaz can be reached at 0975-3399523. Donations can be deposited in her BPI account (#4929-1243-11).

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.